Vascular system-central arteries, percutaneous approach

85815500 Category Share

Vascular system-central arteries, percutaneous approach is an EFRIS commodity class (code 85815500) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

28 items in this category

• 85815508Introduction of analgesics, hypnotics, sedatives into central artery, percutaneous approach
  Exempt
• 85815517Introduction of anti-inflammatory into central artery, percutaneous approach
  Exempt
• 85815506Introduction of antiarrhythmic into central artery, percutaneous approach
  Exempt
• 85815511Introduction of blood brain barrier disruption substance into central artery, percutaneous approach
  Exempt
• 85815521Introduction of clofarabine into central artery, percutaneous approach
  Exempt
• 85815505Introduction of destructive agent into central artery, percutaneous approach
  Exempt
• 85815514Introduction of electrolytic and water balance substance into central artery, percutaneous approach
  Exempt
• 85815525Introduction of high-dose interleukin-2 into central artery, percutaneous approach
  Exempt
• 85815503Introduction of human b-type natriuretic peptide into central artery, percutaneous approach
  Exempt
• 85815527Introduction of immunostimulator into central artery, percutaneous approach
  Exempt
• 85815526Introduction of immunosuppressive into central artery, percutaneous approach
  Exempt
• 85815504Introduction of insulin into central artery, percutaneous approach
  Exempt
• 85815513Introduction of intracirculatory anesthetic into central artery, percutaneous approach
  Exempt
• 85815524Introduction of low-dose interleukin-2 into central artery, percutaneous approach
  Exempt
• 85815522Introduction of monoclonal antibody into central artery, percutaneous approach
  Exempt
• 85815515Introduction of nutritional substance into central artery, percutaneous approach
  Exempt
• 85815518Introduction of other anti-infective into central artery, percutaneous approach
  Exempt
• 85815523Introduction of other antineoplastic into central artery, percutaneous approach
  Exempt
• 85815509Introduction of other diagnostic substance into central artery, percutaneous approach
  Exempt
• 85815502Introduction of other hormone into central artery, percutaneous approach
  Exempt
• 85815512Introduction of other therapeutic substance into central artery, percutaneous approach
  Exempt
• 85815520Introduction of other thrombolytic into central artery, percutaneous approach
  Exempt
• 85815519Introduction of oxazolidinones into central artery, percutaneous approach
  Exempt
• 85815507Introduction of platelet inhibitor into central artery, percutaneous approach
  Exempt
• 85815510Introduction of radioactive substance into central artery, percutaneous approach
  Exempt
• 85815528Introduction of recombinant human-activated protein c into central artery, percutaneous approach
  Exempt
• 85815516Introduction of serum, toxoid and vaccine into central artery, percutaneous approach
  Exempt
• 85815501Introduction of vasopressor into central artery, percutaneous approach
  Exempt